Navigation Links
Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
Date:9/28/2010

PRINCETON, N.J., Sept. 28 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced the appointment of Steven R. Johnson as Vice President, Business Development. Mr. Johnson will be responsible for Laureate's worldwide business development activities, including sales, marketing, business development and project management, supporting the company's contract development, protein manufacturing, testing and aseptic filling businesses.

"Steve brings a proven track record of sales management in the biologics market combined with extensive senior relationships," said Michael A. Griffith, Chief Executive Officer of Laureate Pharma.  "He is an industry leader and brings to Laureate Pharma an impressive background that includes broad international business development experience in contract manufacturing of monoclonal antibodies, biopharmaceuticals and chemical active pharmaceutical ingredients."

"Steve is a great fit at Laureate and is well-positioned to take us to the next level with our clients as we prepare to invest in growth of the business," said Mr. Griffith who recently joined Laureate Pharma as Chief Executive Officer and is also a member of the Board of Directors. He was the Founder and Chief Executive Officer of Aptuit, Inc., and the Chairman and Chief Executive Officer of ChiRex, Inc.

Mr. Johnson joins Laureate from Lonza where he served most recently as Vice President Global Business Development, and previously as Vice President, Sales and Business Development, North America. In both positions, Steve supported several of Lonza's contract manufacturing business units, including cell culture protein manufacturing, microbial protein production and stem cell production. Previously, Steve held the position of Vice President, Sales North America for Degussa Fine Chemicals. He began his career as a microbiologist in Merck's Chemical Manufacturing Division and transitioned to roles of increasing responsibility in purchasing, sourcing and business development. Steve earned a B.S. in Microbiology from the University of Illinois and an MBA from James Madison University.

About Laureate Pharma

Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, NJ.  With more than 30 years of experience, Laureate provides the range of services required for the manufacture of monoclonal antibodies and other biopharmaceutical products produced by mammalian cells including cell line development, media optimization, process development, formulation, pilot production, cGMP production for clinical and commercial supply, aseptic fill/finish, and assistance with regulatory support and CMC documentation. Laureate is a portfolio company of Saints Capital, LLC.

About Saints Capital, LLC.

Saints Capital is a leading direct secondary acquirer of venture capital and private equity investments in emerging growth companies around the globe. It also makes traditional direct venture capital investments on a primary basis and in special situations in technology, healthcare, consumer and industrial companies in the United States. Founded in 2000, Saints provides liquidity for private investors in such markets as investment and commercial banks, buyouts, corporate venture capital and hedge funds. Saints has more than $1 billion of committed capital under management, over 50 completed portfolio transactions and investments in more than 200 companies. For more information, please visit www.saintsvc.com.


'/>"/>
SOURCE Laureate Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Reuters Predicts Nobel Laureates
2. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
3. Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
4. Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion
5. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
6. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
7. Amira Pharmaceuticals Announces IND Submission for Novel LPA1 Antagonist, AM152, for Potential Use in Fibrotic Diseases
8. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2010 Earnings Conference Call on Thursday, September 30, 2010 at 9:00 a.m. ET
9. New Manhattan Research Report Explores the Growing Consumer Demand for Online Health Video and How Pharma Marketers Can Leverage this Format
10. China BCT Further Expands its Footprint by Acquiring 33 Retail Pharmaceutical Stores
11. Keryx Biopharmaceuticals to Present at JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ORANGE COUNTY, Calif. , Oct. 10, 2017  NDS received ... Mobile  — a medical-grade battery-powered display stand specifically designed for ... aims to transform technology into a clinical solution to support the ... costs. Innovative Design ... NDS ZeroWire Mobile Wireless Solution ...
(Date:10/4/2017)...  South Korean-based healthcare product Development Company I.M. Lab ... Kickstarter. The device will educate the user about ,proper, ... efficiency compared to the dated and pricey CPR training ... of the compression for a more informed CPR training. ... raise $5,000. cprCUBE ...
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & Wellness ... Moonlight to raise money for the American Heart Association Heart Walk. Teams of up ... work together to keep their treadmills moving for 5 hours. Treadmills will start at ...
Breaking Medicine News(10 mins):